Combined autophagy and HDAC inhibition: A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors

Devalingam Mahalingam, Monica Mita, John Sarantopoulos, Leslie Wood, Ravi K. Amaravadi, Lisa E. Davis, Alain C. Mita, Tyler J. Curiel, Claudia M. Espitia, Steffan T. Nawrocki, Francis J. Giles, Jennifer S. Carew

Research output: Contribution to journal › Article › peer-review

225 Scopus citations

Fingerprint

Dive into the research topics of 'Combined autophagy and HDAC inhibition: A phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors'. Together they form a unique fingerprint.

Medicine & Life Sciences